Featured News

Celiac Disease Foundation is proud to have been a funder and to participate on the Steering Committee for the FDA Gastroenterology Regulatory Endpoints and Advancement of Therapeutics (GREAT3) workshop. Conceived…

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $142.5 million to support the ongoing development and expansion of an ambitious new resource for health research known as PCORnet, the National Patient-Centered Clinical Research Network.

Celiac Disease Foundation (CDF) is proud to announce that Marilyn G. Geller, Chief Executive Officer, recently received a national award from Alpha Chi Omega Sorority, recognizing her accomplishments and achievements…

Relatively Rare. Relatively Minor. Relatively Easy to Treat. For more than 50 years, the celiac community has been led to believe that the above statements about the disease were true. We…

The CDF Gluten-Free EXPO was the largest yet! Nearly 3000 attendees sampled the best Los Angeles has to offer on May 2nd and 3rd. Life in LA sent their reporter to check out the exciting

On behalf of our patient community, CDF has either directly invested or fought to secure investments in diagnostics, research, and treatment for celiac disease. We have always known that this was a serious disease with broad and often devastating impacts if left undiagnosed and/or untreated. Our 25 years of hard work continues to yield returns. This is from a NY Times article published on April 29, 2015, "Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought."

On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ perspectives on the adequacy of the available therapies.

CDF CEO, Marilyn Geller, will present the celiac patient voice at the May 11 FDA Patient-Focused Drug Development meeting. Have your voice be heard. Complete the CDF Celiac PFDD Survey now.

Celiac Disease Foundation (CDF) – the nation’s leading disease advocacy organization for celiac disease - has received a prestigious Service Grant from The Taproot Foundation, valued at $45,000, to produce its annual report, in celebration of the Foundation’s 25th anniversary.

Irvine, March 19, 2015 – Renegade Racing, a premier running, triathlon & adventure sports production company in Southern California, is excited to partner with Celiac Disease Foundation’s Team Gluten-Free (TGF)…